Memo Therapeutics | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

16,808 results for “Memo Therapeutics”

Trials

View all 3694 →

MEMO-Medical Marijuana and Opioids Study

257 participants · First posted Aug 31, 2017

EMDR on Pain in Patients With in Patients Rheumatoid Arthritis

64 participants · First posted Jul 13, 2023

Clinical Performance of BIS-GMA Free Dental Resin Composite

40 participants · First posted Jul 29, 2022

Drugs

View all 3153 →

CMV (Memo Therapeutics)

Nipah (Memo Therapeutics)

Monoclonal antibody (first-in-class therapeutic antibody)

Potravitug

Manufacturer: Memo Therapeutics AG

Conditions: BK polyomavirus infection, BKPyV nephropathy (BKPyVAN)

Organizations

View all 1127 →

Memo Therapeutics AG

Switzerland

JASPER THERAPEUTICS, INC

United States

CRISPR Therapeutics, Inc.

United States

News

View all 8834 →

Memo Therapeutics Completes Enrollment in Phase II Trial of Potravitug for BK Viremia

Ipsen Acquires Memo Therapeutics in Deal Worth Up to €700 Million, Validating Antibody Discovery Platform

Memo Therapeutics Demonstrates Therapeutic Antibodies Can Cross Kidney Barrier, Supporting BK Virus Treatment Approach

Page 1 of 1681